PMID- 26985913 OWN - NLM STAT- MEDLINE DCOM- 20170623 LR - 20211204 IS - 1952-4013 (Electronic) IS - 1167-1122 (Linking) VI - 26 IP - 3 DP - 2016 Jun 1 TI - Epithelial skin cancers after kidney transplantation: a retrospective single-centre study of 376 recipients. PG - 265-70 LID - 10.1684/ejd.2016.2758 [doi] AB - Post-transplant non-melanoma skin cancers (NMSC) are the most common malignancies in kidney transplant recipients. To analyse risk factors associated with the occurrence of basal cell carcinomas (BBC) and squamous cell carcinomas (SCC) in kidney transplant recipients. Statistical analysis was performed on 376 kidney transplant recipients screened for NMSC in 2002-2009 and followed until 2013. NMSC developed in 23.67% of individuals with an SCC/BCC ratio of 2.15:1 and an age-standardised incidence ratio (IR) of 2.71 cases (95% CI: 1.97-3.46) per 100 patients/year. Based on multivariable analysis, NMSC occurrence significantly correlated with higher age (p<0.001), fair skin type (p = 0.01), and particularly SCCs with male gender (p = 0.001). Patients with >10 actinic keratoses were at higher risk of developing NMSCs (IRR = 2.95; 95% CI: 1.97-4.42; p<0.001) and more prone to SCCs, compared to BCCs (p = 0.04). Also, more SCC carriers had high counts of warty lesions (p = 0.006). Calcineurin inhibitors were associated with higher NMSC incidence (IRR = 2.81; 95% CI: 1.1-7.01; p = 0.03), while no difference was seen with the mammalian target of rapamycin (mTOR) inhibitors. Our results confirm an influence of the individual immunosuppressive regimen, in addition to the duration of immunosuppression, and suggest that older patients, males, fair skinned recipients or those affected with high counts of actinic keratoses (field cancerisation) are particularly prone to development of NMSC. FAU - Kaufmann, Robin Adrian AU - Kaufmann RA AD - Department of Dermatology, Inselspital, University Hospital Bern, Freiburgstrasse 4, CH-3010 Bern, Switzerland. FAU - Oberholzer, Patrick Antony AU - Oberholzer PA AD - Department of Dermatology, Inselspital, University Hospital Bern, Freiburgstrasse 4, CH-3010 Bern, Switzerland. FAU - Cazzaniga, Simone AU - Cazzaniga S AD - Department of Dermatology, Inselspital, University Hospital Bern, Freiburgstrasse 4, CH-3010 Bern, Switzerland, Centro Studi GISED, Via Garibaldi 13/15, I-24122 Bergamo, Italy. FAU - Hunger, Robert Emil AU - Hunger RE AD - Department of Dermatology, Inselspital, University Hospital Bern, Freiburgstrasse 4, CH-3010 Bern, Switzerland. LA - eng PT - Journal Article PL - France TA - Eur J Dermatol JT - European journal of dermatology : EJD JID - 9206420 RN - 0 (Calcineurin Inhibitors) RN - 0 (Immunosuppressive Agents) RN - 0 (Protein Kinase Inhibitors) SB - IM MH - Adult MH - Age Factors MH - Calcineurin Inhibitors/therapeutic use MH - Carcinoma, Basal Cell/*epidemiology MH - Carcinoma, Squamous Cell/*epidemiology MH - Female MH - Humans MH - Immunosuppression Therapy/*methods MH - Immunosuppressive Agents/*therapeutic use MH - Incidence MH - Keratosis, Actinic/epidemiology MH - *Kidney Transplantation MH - Longitudinal Studies MH - Male MH - Middle Aged MH - Protein Kinase Inhibitors/therapeutic use MH - Retrospective Studies MH - Risk Factors MH - Sex Factors MH - Skin Neoplasms/*epidemiology MH - Skin Pigmentation OTO - NOTNLM OT - immunosuppression OT - kidney transplant recipients OT - non-melanoma skin cancer EDAT- 2016/03/18 06:00 MHDA- 2017/06/24 06:00 CRDT- 2016/03/18 06:00 PHST- 2016/03/18 06:00 [entrez] PHST- 2016/03/18 06:00 [pubmed] PHST- 2017/06/24 06:00 [medline] AID - ejd.2016.2758 [pii] AID - 10.1684/ejd.2016.2758 [doi] PST - ppublish SO - Eur J Dermatol. 2016 Jun 1;26(3):265-70. doi: 10.1684/ejd.2016.2758.